BioCorRx (BICX) Receivables - Other (2016 - 2026)

BioCorRx has disclosed Receivables - Other across 11 years of filings, most recently posting $121720.0 for Q1 2026.

• Receivables - Other for Q1 2026 came in at $121720.0, down 20.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $121720.0 (down 20.63% YoY), and the FY2025 annual result was $52026.0, changed N/A from the prior year.
• Receivables - Other came in at $121720.0 for Q1 2026 at BioCorRx, up from $52026.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $958111.0 in Q2 2022 to a low of $4991.0 in Q3 2023.
• The 5-year median for Receivables - Other is $122186.0 (2022), against an average of $283552.7.
• Across the five-year window, Receivables - Other surged 63774.07% in 2022 and sank 99.24% in 2023, its largest moves.
• BioCorRx's Receivables - Other stood at $122652.0 in 2022, then tumbled by 37.82% to $76266.0 in 2023, then surged by 311.94% to $314170.0 in 2024, then tumbled by 83.44% to $52026.0 in 2025, then jumped by 133.96% to $121720.0 in 2026.
• The last three Receivables - Other figures came in at $121720.0 (Q1 2026), $52026.0 (Q4 2025), and $761515.0 (Q3 2025), per Business Quant data.